Context
In the pharmaceutical field, the synthetic matrices used to convey active ingredients raise issues of toxicity and environmental impact. A promising alternative lies in the use of biosourced matrices, derived from renewable, biocompatible and biodegradable plant resources.
Biosourced matrices can reduce environmental impact by 50-70% compared with synthetic polymers, by saving solvents and energy during processing.
Objectives
Bio4Health aims to design new active ingredient vectors – for oral or transdermal administration – from plant biomasses transformed using wet milling, prilling or 3D printing techniques.
The aim is twofold: to reduce the environmental footprint of pharmaceutical production and to improve the biological compatibility of healthcare products.
80 % of excipients used in medicines are of petrochemical origin
3 plant biomasses studied (spirulina, citrus, algae)
2 galenic forms developed (particles and patches)
